{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:56:41Z","timestamp":1790290601558,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070046"],"award-info":[{"award-number":["82070046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10557-025-07816-9","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T05:42:30Z","timestamp":1764394950000},"page":"1301-1317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["RELM-\u03b2 Augmented Hypoxia-Induced Pulmonary Hypertension Through Interacting with GIPC1, OR1N1 and CLIC4"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4717-4772","authenticated-orcid":false,"given":"Chunlong","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoushuo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"7816_CR1","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0205-2022","volume":"18","author":"A Krompa","year":"2022","unstructured":"Krompa A, Marino P. Diagnosis and management of pulmonary hypertension related to chronic respiratory disease. Breathe. 2022;18:220205. https:\/\/doi.org\/10.1183\/20734735.0205-2022.","journal-title":"Breathe"},{"key":"7816_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10557-024-07588-8","volume":"39","author":"K Ichimura","year":"2025","unstructured":"Ichimura K, Gross A, Mathew RO, et al. Cardiorenal syndrome in right heart failure due to pulmonary arterial hypertension-the right ventricle as a therapeutic target to improve renal function. Cardiovasc Drugs Ther. 2025;39:373\u201384. https:\/\/doi.org\/10.1007\/s10557-024-07588-8.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7816_CR3","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMra2000348","volume":"385","author":"PM Hassoun","year":"2021","unstructured":"Hassoun PM. Pulmonary arterial hypertension. N Engl J Med. 2021;385:2361\u201376. https:\/\/doi.org\/10.1056\/NEJMra2000348.","journal-title":"N Engl J Med"},{"key":"7816_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01914-2018","author":"SD Nathan","year":"2019","unstructured":"Nathan SD, Barbera JA, Gaine SP, et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.01914-2018.","journal-title":"Eur Respir J"},{"key":"7816_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-024-07655-0","author":"R Lan","year":"2024","unstructured":"Lan R, Zhang MJ, Liu K, et al. Cytochrome p450-derived epoxyeicosatrienoic acid, the regulation of cardiovascular-related diseases, and the implication for pulmonary hypertension. Cardiovasc Drugs Ther. 2024. https:\/\/doi.org\/10.1007\/s10557-024-07655-0.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7816_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/diseases6020038","author":"NSH Lan","year":"2018","unstructured":"Lan NSH, Massam BD, Kulkarni SS, Lang CC. Pulmonary arterial hypertension: pathophysiology and treatment. Diseases. 2018. https:\/\/doi.org\/10.3390\/diseases6020038.","journal-title":"Diseases"},{"key":"7816_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117419","volume":"246","author":"L Han","year":"2020","unstructured":"Han L, Song N, Hu X, et al. Inhibition of relm-\u03b2 prevents hypoxia-induced overproliferation of human pulmonary artery smooth muscle cells by reversing plc-mediated kcnk3 decline. Life Sci. 2020;246:117419. https:\/\/doi.org\/10.1016\/j.lfs.2020.117419.","journal-title":"Life Sci"},{"key":"7816_CR8","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1161\/01.Res.0000073999.07698.33","volume":"92","author":"X Teng","year":"2003","unstructured":"Teng X, Li D, Champion HC, Johns RA. Fizz1\/relmalpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties. Circ Res. 2003;92:1065\u20137. https:\/\/doi.org\/10.1161\/01.Res.0000073999.07698.33.","journal-title":"Circ Res"},{"key":"7816_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1165\/rcmb.2008-0271OC","volume":"41","author":"DJ Angelini","year":"2009","unstructured":"Angelini DJ, Su Q, Yamaji-Kegan K, et al. Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension. Am J Respir Cell Mol Biol. 2009;41:553\u201361. https:\/\/doi.org\/10.1165\/rcmb.2008-0271OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"7816_CR10","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1016\/j.yexcr.2006.07.024","volume":"312","author":"Q Tong","year":"2006","unstructured":"Tong Q, Zheng L, Li B, et al. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells. Exp Cell Res. 2006;312:3559\u201369. https:\/\/doi.org\/10.1016\/j.yexcr.2006.07.024.","journal-title":"Exp Cell Res"},{"key":"7816_CR11","doi-asserted-by":"publisher","first-page":"L263","DOI":"10.1152\/ajplung.90416.2008","volume":"297","author":"C Fan","year":"2009","unstructured":"Fan C, Su Q, Li Y, et al. Hypoxia-induced mitogenic factor\/fizz1 induces intracellular calcium release through the plc-ip(3) pathway. Am J Physiol Lung Cell Mol Physiol. 2009;297:L263\u2013270. https:\/\/doi.org\/10.1152\/ajplung.90416.2008.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"7816_CR12","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.addr.2010.11.001","volume":"63","author":"X Zhao","year":"2011","unstructured":"Zhao X, Guan JL. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev. 2011;63:610\u20135. https:\/\/doi.org\/10.1016\/j.addr.2010.11.001.","journal-title":"Adv Drug Deliv Rev"},{"key":"7816_CR13","doi-asserted-by":"publisher","first-page":"16309","DOI":"10.1074\/jbc.275.21.16309","volume":"275","author":"Y Sonoda","year":"2000","unstructured":"Sonoda Y, Matsumoto Y, Funakoshi M, Yamamoto D, Hanks SK, Kasahara T. Anti-apoptotic role of focal adhesion kinase (fak). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of fak in a human leukemic cell line, hl-60. J Biol Chem. 2000;275:16309\u201315. https:\/\/doi.org\/10.1074\/jbc.275.21.16309.","journal-title":"J Biol Chem"},{"key":"7816_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.yexcr.2016.12.021","volume":"351","author":"C Lin","year":"2017","unstructured":"Lin C, Li X, Luo Q, et al. Relm-\u03b2 promotes human pulmonary artery smooth muscle cell proliferation via fak-stimulated surviving. Exp Cell Res. 2017;351:43\u201350. https:\/\/doi.org\/10.1016\/j.yexcr.2016.12.021.","journal-title":"Exp Cell Res"},{"key":"7816_CR15","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41419-022-05091-2","volume":"13","author":"R Liu","year":"2022","unstructured":"Liu R, Xu C, Zhang W, et al. Fundc1-mediated mitophagy and hif1\u03b1 activation drives pulmonary hypertension during hypoxia. Cell Death Dis. 2022;13:634. https:\/\/doi.org\/10.1038\/s41419-022-05091-2.","journal-title":"Cell Death Dis"},{"key":"7816_CR16","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1002\/cbic.202100223","volume":"22","author":"MA Arai","year":"2021","unstructured":"Arai MA, Sakuraba K, Makita Y, Hara Y, Ishibashi M. Evaluation of naturally occurring hif-1 inhibitors for pulmonary arterial hypertension. Chembiochem. 2021;22:2799\u2013804. https:\/\/doi.org\/10.1002\/cbic.202100223.","journal-title":"Chembiochem"},{"key":"7816_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1161\/atvbaha.115.306710","volume":"36","author":"RA Johns","year":"2016","unstructured":"Johns RA, Takimoto E, Meuchel LW, et al. Hypoxia-inducible factor 1\u03b1 is a critical downstream mediator for hypoxia-induced mitogenic factor (fizz1\/relm\u03b1)-induced pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2016;36:134\u201344. https:\/\/doi.org\/10.1161\/atvbaha.115.306710.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7816_CR18","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1038\/s41388-018-0290-4","volume":"37","author":"D Grun","year":"2018","unstructured":"Grun D, Adhikary G, Eckert RL. Nrp-1 interacts with gipc1 and \u03b16\/\u03b24-integrins to increase yap1\/\u2206np63\u03b1-dependent epidermal cancer stem cell survival. Oncogene. 2018;37:4711\u201322. https:\/\/doi.org\/10.1038\/s41388-018-0290-4.","journal-title":"Oncogene"},{"key":"7816_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1126\/science.abg3067","volume":"375","author":"M Orecchioni","year":"2022","unstructured":"Orecchioni M, Kobiyama K, Winkels H, et al. Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production. Science. 2022;375:214\u201321. https:\/\/doi.org\/10.1126\/science.abg3067.","journal-title":"Science"},{"key":"7816_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1165\/rcmb.2022-0111OC","volume":"68","author":"MM Alzaydi","year":"2023","unstructured":"Alzaydi MM, Abdul-Salam VB, Whitwell HJ, et al. Intracellular chloride channels regulate endothelial metabolic reprogramming in pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2023;68:103\u201315. https:\/\/doi.org\/10.1165\/rcmb.2022-0111OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"7816_CR21","doi-asserted-by":"publisher","DOI":"10.3791\/63839","author":"L Qin","year":"2022","unstructured":"Qin L, Jiang B, Zsebo K, Duckers HJ, Simons M, Chen PY. Multiple intravenous bolus dosing and invasive hemodynamic assessment in a hypoxia-induced mouse pulmonary artery hypertension model. J Vis Exp. 2022. https:\/\/doi.org\/10.3791\/63839.","journal-title":"J Vis Exp"},{"key":"7816_CR22","doi-asserted-by":"publisher","first-page":"L582","DOI":"10.1152\/ajplung.90526.2008","volume":"296","author":"DJ Angelini","year":"2009","unstructured":"Angelini DJ, Su Q, Yamaji-Kegan K, et al. Hypoxia-induced mitogenic factor (himf\/fizz1\/relmalpha) induces the vascular and hemodynamic changes of pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2009;296:L582\u2013593. https:\/\/doi.org\/10.1152\/ajplung.90526.2008.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"7816_CR23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10557-024-07568-y","volume":"39","author":"B Wang","year":"2025","unstructured":"Wang B, Xu Y, Huang Y, et al. Mir-210-5p promotes pulmonary hypertension by blocking ATP2A2. Cardiovasc Drugs Ther. 2025;39:711\u20139. https:\/\/doi.org\/10.1007\/s10557-024-07568-y.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7816_CR24","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10557-023-07458-9","volume":"38","author":"P Ye","year":"2024","unstructured":"Ye P, Jiang XM, Qian WC, Zhang J. Inhibition of PCSK9 improves the development of pulmonary arterial hypertension via down-regulating NOTCH3 expression. Cardiovasc Drugs Ther. 2024;38:1223\u201334. https:\/\/doi.org\/10.1007\/s10557-023-07458-9.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7816_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-024-07618-5","author":"NSC Souza","year":"2024","unstructured":"Souza NSC, Barenco-Marins T, Ferraz AP, et al. Low thyroid hormones level attenuates mitochondrial dysfunction and right ventricular failure in pulmonary hypertensive rats. Cardiovasc Drugs Ther. 2024. https:\/\/doi.org\/10.1007\/s10557-024-07618-5.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7816_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176077","volume":"959","author":"S Kong","year":"2023","unstructured":"Kong S, Yu J, Li HF, et al. A ring n(ch(3))(2)-based derivative of resveratrol inhibits pulmonary vascular remodeling in hypoxia pulmonary hypertension. Eur J Pharmacol. 2023;959:176077. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176077.","journal-title":"Eur J Pharmacol"},{"key":"7816_CR27","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1161\/circulationaha.113.006797","volume":"129","author":"B Wojciak-Stothard","year":"2014","unstructured":"Wojciak-Stothard B, Abdul-Salam VB, Lao KH, et al. Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertension. Circulation. 2014;129:1770\u201380. https:\/\/doi.org\/10.1161\/circulationaha.113.006797.","journal-title":"Circulation"},{"key":"7816_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1164\/rccm.200908-1189OC","volume":"181","author":"S Matsuoka","year":"2010","unstructured":"Matsuoka S, Washko GR, Yamashiro T, et al. Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med. 2010;181:218\u201325. https:\/\/doi.org\/10.1164\/rccm.200908-1189OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"7816_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10557-023-07503-7","volume":"39","author":"TS Barenco-Marins","year":"2025","unstructured":"Barenco-Marins TS, Seara FAC, Ponte CG, Nascimento JHM. Pulmonary circulation under pressure: pathophysiological and therapeutic implications of Bk channel. Cardiovasc Drugs Ther. 2025;39:415\u201333. https:\/\/doi.org\/10.1007\/s10557-023-07503-7.","journal-title":"Cardiovasc Drugs Ther"},{"key":"7816_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1108304","volume":"14","author":"JM Lade","year":"2023","unstructured":"Lade JM, Andrade MR, Undem C, et al. Hypoxia enhances interactions between na(+)\/h(+) exchanger isoform 1 and actin filaments via ezrin in pulmonary vascular smooth muscle. Front Physiol. 2023;14:1108304. https:\/\/doi.org\/10.3389\/fphys.2023.1108304.","journal-title":"Front Physiol"},{"key":"7816_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3235102","volume":"2022","author":"Y Xiang","year":"2022","unstructured":"Xiang Y, Zheng F, Zhang Q, et al. Tanreqing injection regulates cell function of hypoxia-induced human pulmonary artery smooth muscle cells (hpasmcs) through trpc1\/cx3cl1 signaling pathway. Oxid Med Cell Longev. 2022;2022:3235102. https:\/\/doi.org\/10.1155\/2022\/3235102.","journal-title":"Oxid Med Cell Longev"},{"key":"7816_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4049\/jimmunol.1000964","volume":"187","author":"T Liu","year":"2011","unstructured":"Liu T, Baek HA, Yu H, et al. Fizz2\/relm-\u03b2 induction and role in pulmonary fibrosis. J Immunol. 2011;187:450\u201361. https:\/\/doi.org\/10.4049\/jimmunol.1000964.","journal-title":"J Immunol"},{"key":"7816_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.plefa.2018.03.002","volume":"135","author":"Y Xing","year":"2018","unstructured":"Xing Y, Zheng X, Qi J, et al. 15-lipoxygenase\/15-hydroxyeicosanoid and activator protein 1 contribute to hypoxia-induced pulmonary artery smooth muscle cells phenotype alteration. Prostaglandins Leukot Essent Fatty Acids. 2018;135:22\u20139. https:\/\/doi.org\/10.1016\/j.plefa.2018.03.002.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"7816_CR34","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1164\/rccm.202203-0450OC","volume":"207","author":"S Sangam","year":"2023","unstructured":"Sangam S, Sun X, Schwantes-An TH, et al. Sox17 deficiency mediates pulmonary hypertension: at the crossroads of sex, metabolism, and genetics. Am J Respir Crit Care Med. 2023;207:1055\u201369. https:\/\/doi.org\/10.1164\/rccm.202203-0450OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"7816_CR35","doi-asserted-by":"publisher","first-page":"757168","DOI":"10.3389\/fcell.2021.757168","volume":"9","author":"X Li","year":"2021","unstructured":"Li X, Liu C, Qi W, et al. Endothelial dec1-ppar\u03b3 axis impairs proliferation and apoptosis homeostasis under hypoxia in pulmonary arterial hypertension. Front Cell Dev Biol. 2021;9:757168. https:\/\/doi.org\/10.3389\/fcell.2021.757168.","journal-title":"Front Cell Dev Biol"},{"key":"7816_CR36","doi-asserted-by":"publisher","first-page":"32527","DOI":"10.1074\/jbc.M803059200","volume":"283","author":"NY Lee","year":"2008","unstructured":"Lee NY, Ray B, How T, Blobe GC. Endoglin promotes transforming growth factor beta-mediated Smad 1\/5\/8 signaling and inhibits endothelial cell migration through its association with Gipc. J Biol Chem. 2008;283:32527\u201333. https:\/\/doi.org\/10.1074\/jbc.M803059200.","journal-title":"J Biol Chem"},{"key":"7816_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/circresaha.118.313705","volume":"124","author":"VB Abdul-Salam","year":"2019","unstructured":"Abdul-Salam VB, Russomanno G, Chien-Nien C, et al. Clic4\/arf6 pathway. Circ Res. 2019;124:52\u201365. https:\/\/doi.org\/10.1161\/circresaha.118.313705.","journal-title":"Circ Res"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-025-07816-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:07:34Z","timestamp":1784624854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-025-07816-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["7816"],"URL":"https:\/\/doi.org\/10.1007\/s10557-025-07816-9","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"8 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for the animal experiment was obtained from the Hunan Normal University Biomedical Research Ethics Committee under license number (2020-086).","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors did not use generative AI or AI-assisted technologies in the development of this manuscript\u201d.","order":4,"name":"Ethics","label":"Artificial Intelligence","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflicts of interest.","order":5,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}